EFDID: 579399EFD: View Filing

Issuer: Aprea Therapeutics, Inc. (0001781983) - D

Accession: 0001781983-25-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001781983
  • Entity Name:
    Aprea Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    3805 OLD EASTON ROAD
    DOYLESTOWN, PA 18902
  • Persons:
    Related Persons 10
    Oren Gilad
    Executive Officer, Director
    John P. Hamill
    Executive Officer
    Richard Peters
    Director
    Jean-Pierre Bizzari
    Director
    Marc Duey
    Director
    Michael Grissinger
    Director
    Gabriela Gruia
    Director
    John B. Henneman
    Director
    Rifat Pamukcu
    Director
    Bernd Seizinger
    Director
EDGAR: Offering Information
  • Accession Date:
    12/23/2025
  • First Sale Date:
    12/10/2025
  • Offering Amount:
    $5,783,766
  • Amount Sold:
    $3,055,822
  • Amount Remaining:
    $2,727,944
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Includes up to $2,727,943.92 in offering proceeds upon the cash exercise of common stock purchase warrants.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Maxim Group LLC 120708 None None FL, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Aprea Therapeutics, Inc./s/ Oren Gilad, Ph.D.Oren Gilad, Ph.D.President and CEO2025-12-23